ADAPY supply chain intelligence for Adaptimmune Therapeutics PLC: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Adaptimmune Therapeutics PLC (ADAPY) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CELUW | CELUW | 72% | Reciprocal relationship from CELUW graph: . Our pipeline reflects our intent to leverage the unique biology of the placenta to develop placental-derived allogeneic cells for indications where the dem… |
| CRBU | Caribou Biosciences, Inc. | 72% | Reciprocal relationship from CRBU graph: Reciprocal relationship from ADAPY graph: Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in th… |
| INAB | IN8bio, Inc. | 72% | Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intellectual Property.” Sales and Marketing Given our stage of development, we have not ye… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CELUW | CELUW | 72% | Reciprocal relationship from CELUW graph: Reciprocal relationship from ADAPY graph: Reciprocal relationship from CELUW graph: . Our pipeline reflects our intent to leverage the unique biology of the … |
| CRBU | Caribou Biosciences, Inc. | 72% | Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c… |
| INAB | IN8bio, Inc. | 72% | Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intellectual Property.” Sales and Marketing Given our stage of development, we have not ye… |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| CRBU | Caribou Biosciences, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| INAB | IN8bio, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CELUW | Celularity Inc | 100.00 | 1 | ['customer', 'supplier'] |
| EDIT | Editas Medicine, Inc. | 50.00 | 2 | |
| ALLO | Allogene Therapeutics, Inc. | 50.00 | 2 | |
| ATRA | Atara Biotherapeutics, Inc. | 50.00 | 2 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 50.00 | 2 | |
| CGEM | Cullinan Therapeutics, Inc. | 50.00 | 2 | |
| ARTV | Artiva Biotherapeutics, Inc. | 50.00 | 2 | |
| HCWB | HCW Biologics Inc. | 50.00 | 2 | |
| BMY | Bristol-Myers Squibb Company | 50.00 | 2 | |
| IPSC | Century Therapeutics, Inc. | 50.00 | 2 | |
| JANX | Janux Therapeutics, Inc. | 50.00 | 2 | |
| ORGO | Organogenesis Holdings Inc. | 50.00 | 2 | |
| MGX | Metagenomi Therapeutics, Inc. | 50.00 | 2 | |
| SGMO | Sangamo Therapeutics, Inc. | 50.00 | 2 | |
| IOVA | Iovance Biotherapeutics, Inc. | 50.00 | 2 | |
| JNJ | Johnson & Johnson | 50.00 | 2 | |
| LEGN | Legend Biotech Corporation | 50.00 | 2 | |
| NTLA | Intellia Therapeutics, Inc. | 50.00 | 2 |